BMRN vs STEM · P/E 40, rev $2.85B vs rev $144.6M
Biomarin Pharmaceutical Inc (BMRN) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. STEM currently screens at market cap $82.1M.
Not investment advice. Open the BMRN and STEM stock pages for the full models.
Not investment advice.